Femasys Inc. (NASDAQ:FEMY) Receives $5.50 Average PT from Analysts

by · The Markets Daily

Femasys Inc. (NASDAQ:FEMY – Get Free Report) has earned an average rating of “Moderate Buy” from the five research firms that are covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation and four have issued a buy recommendation on the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $5.50.

FEMY has been the topic of several recent research reports. Weiss Ratings restated a “sell (e+)” rating on shares of Femasys in a report on Thursday, January 22nd. Wall Street Zen upgraded Femasys from a “sell” rating to a “hold” rating in a research note on Saturday. Laidlaw assumed coverage on Femasys in a report on Thursday, November 20th. They set a “buy” rating and a $6.50 price objective on the stock. Finally, Lake Street Capital assumed coverage on Femasys in a research note on Tuesday, March 3rd. They issued a “buy” rating and a $1.50 price objective on the stock.

View Our Latest Report on Femasys

Hedge Funds Weigh In On Femasys

Institutional investors have recently modified their holdings of the company. Kovack Advisors Inc. acquired a new stake in shares of Femasys in the fourth quarter worth $27,000. HRT Financial LP acquired a new position in Femasys in the 4th quarter valued at $30,000. Cetera Investment Advisers bought a new position in Femasys in the 4th quarter worth $36,000. Osaic Holdings Inc. bought a new position in Femasys in the 2nd quarter worth $45,000. Finally, State Street Corp lifted its position in Femasys by 43.5% during the 4th quarter. State Street Corp now owns 80,869 shares of the company’s stock worth $47,000 after acquiring an additional 24,500 shares during the last quarter. Institutional investors own 65.27% of the company’s stock.

Femasys Stock Down 1.9%

FEMY stock opened at $0.52 on Tuesday. The company has a current ratio of 1.16, a quick ratio of 0.61 and a debt-to-equity ratio of 0.01. Femasys has a 1 year low of $0.31 and a 1 year high of $1.76. The company has a fifty day simple moving average of $0.57 and a 200 day simple moving average of $0.62. The firm has a market cap of $30.41 million, a PE ratio of -0.72 and a beta of -2.53.

About Femasys

(Get Free Report)

Femasys International, Inc is a medical device company focused on the research, development and commercialization of innovative technologies for interventional women’s health applications. The company’s core activities center on creating minimally invasive diagnostic and therapeutic products designed to address uterine cavity evaluation and treatment and to improve outcomes in gynecological care.

The company’s flagship product, the FemVue® hydrosonography system, is a single-use catheter-based device that enhances visualization of the uterine cavity through saline infusion sonography.

Recommended Stories